Exonate
Latest round
- Angel
Last raised
- Jul 2016
Total raised
- $3.8M
Investors
- 10
About Exonate
Exonate Limited specializes in developing innovative therapies for retinal vascular diseases.Exonate Limited is focused on developing therapies for retinal vascular diseases. Founded in 2013, the company is headquartered in Cambridge, UK. Lucy Donaldson is the founder, and she has a history of involvement in the biopharmaceutical sector.Exonate's primary product offering is EXN407, aimed at becoming the first topical therapy for retinal vascular diseases, specifically for diabetic retinopathy and diabetic macular oedema. This product works by modulating alternative mRNA splicing to address pathological blood vessel formation contributing to these diseases.Exonate's revenue model relies on partnerships and potential licensing agreements for EXN407. Collaborative efforts with healthcare providers and pharmaceutical partners involve supplying innovative therapies for clinical use. Specific geographic regions for expansion have not been disclosed, but the company's strategy includes scaling operations to capture market segments for treatments addressing retinal vascular diseases.
Who invested in Exonate
10 investors across 3 rounds
See all investors in Exonate
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exonate
Who invested in Exonate?
Exonate has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exonate raised?
Exonate has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Exonate last raise money?
Exonate's most recent round on record is a Angel, in Jul 2016.
What does Exonate do?
Exonate Limited specializes in developing innovative therapies for retinal vascular diseases.
Where is Exonate headquartered?
Exonate is headquartered in Cambridge, UK.
Which VCs invest in companies like Exonate?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Exonate's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Exonate? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.